GO
Loading...

Edwards Lifesciences Corp

More

  • Business Highlights Monday, 14 Apr 2014 | 5:46 PM ET

    WASHINGTON— U.S. retail sales in March rose by the largest amount in 18 months, led by strong gains in sales of autos, furniture and a number of other products. The 1.1 percent jump reported by the Commerce Department on Monday was the best showing since September 2012. WASHINGTON— The calendar shows April 15, and you haven't even started on your federal tax return?

  • *Citigroup is one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks closed higher on Monday as Citigroup's earnings and strong retail sales gave investors reasons to buy equities despite a resurgence of geopolitical uncertainties.

  • WebMd and Citigroup are big market movers Monday, 14 Apr 2014 | 4:32 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Edwards Lifesciences Corp., up $8.03 to $81. Citigroup Inc., up $1.99 to $47.67.

  • *Citigroup one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks rose on Monday, rebounding after a sharp selloff in the previous session as strong results from Citigroup and bullish retail sales data lifted sentiment.

  • Edwards jumps after injunction against Medtronic Monday, 14 Apr 2014 | 12:52 PM ET

    On Friday the companies said the U.S. District Court for the District of Delaware granted a preliminary injunction that blocks sales of Medtronic's CoreValve in the U.S. The ruling doesn't affect clinical trials of CoreValve in the U.S. or sales in other countries, Medtronic said. Medtronic Inc. stock lost $1.20, or 2 percent, to $58.

  • April 14- Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.

  • NEW YORK, April 14- U.S. stocks bounced back on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • US stocks recover some ground on retail sales gain Monday, 14 Apr 2014 | 9:13 AM ET

    But the market pushed higher from the get-go Monday, receiving a boost from solid earnings from Citigroup and a strong pickup in retail sales last month. Among the stocks that rose sharply were WebMD, Edwards Lifesciences and Goodrich Petroleum. Citigroup helped stoke the rally.

  • NEW YORK, April 14- U.S. stocks were set to open higher on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • *Edwards Lifesciences shares rally after court ruling. *Ukraine's acting president threatens military action. NEW YORK, April 14- U.S. stock index futures edged higher on Monday, following a slarge selloff last session, with earnings results from Citigroup lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • WASHINGTON, March 30- The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

  • March 27- Baxter International Inc said it would spin off its biotechnology operations into a publicly traded company by the middle of next year, leaving behind its core medical technology business.

  • Feb 18- Medtronic Inc on Tuesday reported a lower quarterly net profit after it took charges for an experimental blood pressure device that failed to prove effective in a clinical study. Medtronic shares fell 2.3 percent to $55.56 in morning trading on the New York Stock Exchange.

  • Feb 18- Medtronic Inc on Tuesday reported lower quarterly net earnings due to charges for the failed clinical study of a treatment being developed for high blood pressure. Excluding the charges and other one-time items, Medtronic earned 91 cents a share, in line with the analysts' average estimate, according to Thomson Reuters I/B/E/S.

  • After-hours buzz: Yum, Take-Two, Hartford & More Monday, 3 Feb 2014 | 4:51 PM ET

    Companies making headlines after the bell Monday.

  • Jan 17- Medtronic Inc's minimally invasive system for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

  • Jan 17- Medtronic Inc's minimally invasive system for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

  • Jan 15- A U.S. jury strengthened Edwards Lifesciences Corp's efforts to protect sales of the company's transcatheter heart valve implants, by ruling that a competing product from Medtronic Inc infringes its patent.

  • Cramer: Laggard about to play catch up? Wednesday, 15 Jan 2014 | 6:45 PM ET

    Most stocks that ended 2013 in negative territory did so for a reason. However, sometimes those reasons change.

  • Unloved stocks: Cramer sifts through 5 S&P laggards Monday, 6 Jan 2014 | 6:40 PM ET

    Early in January, pros take a long hard look at the worst performing stocks from the previous year. What does Jim Cramer see?

Most Popular Video

Thursday, 17 Apr 2014 | 4:13 PM ET

Dissecting today's market activity and the current state of financials, with Yra Harris, Praxis Trading partner; Larry Glazer, Mayflower Advisors; CNBC contributor Carol Roth; "Fast Money" Guy Adami and CNBC's Kate Kelly.

Thursday, 17 Apr 2014 | 5:46 PM ET

CNBC voice over talent Jim Birdsall shares the top 5 sayings from traders on "Fast Money" over the years.

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.